Chemoinformaics analysis of Tubocurarine chloride
| Molecular Weight | 609.743 | nRot | 2 |
| Heavy Atom Molecular Weight | 568.415 | nRig | 42 |
| Exact Molecular Weight | 609.296 | nRing | 8 |
| Solubility: LogS | -2.513 | nHRing | 4 |
| Solubility: LogP | 4.544 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 86 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 4 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 6 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 41 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 37 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 24 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 24 |
| nHA | 7 | APOL | 96.1405 |
| nHD | 2 | BPOL | 52.0655 |
| QED | 0.245 |
| Synth | 5.993 |
| Natural Product Likeliness | 2.261 |
| NR-PPAR-gamma | 0.03 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.995 |
| HIA | 0.928 |
| CACO-2 | -5.819 |
| MDCK | 0.0000287 |
| BBB | 0.028 |
| PPB | 0.51376 |
| VDSS | 0.787 |
| FU | 0.389837 |
| CYP1A2-inh | 0.05 |
| CYP1A2-sub | 0.957 |
| CYP2c19-inh | 0.044 |
| CYP2c19-sub | 0.795 |
| CYP2c9-inh | 0.015 |
| CYP2c9-sub | 0.361 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.959 |
| CYP3a4-inh | 0.042 |
| CYP3a4-sub | 0.944 |
| CL | 3.052 |
| T12 | 0.904 |
| hERG | 0.939 |
| Ames | 0.124 |
| ROA | 0.451 |
| SkinSen | 0.89 |
| Carcinogencity | 0.043 |
| EI | 0.005 |
| Respiratory | 0.243 |
| NR-Aromatase | 0.123 |
| Antiviral | Yes |
| Prediction | 0.879309 |